Notes for procurement, R&D, and QA teams who treat gelatin as a strategic ingredient rather than a commodity line. Market context, buyer vocabulary, and the questions worth asking before an LC opens - written from a single-source distributor's vantage point.
Five overlapping forces - clean-label, the protein narrative, the gummy boom, pharma's excipient preference, and circular-economy sourcing - are turning a century-old ingredient into a strategic line item.
Read the article →
A bloom value with no test method. A vague origin claim. Micro data that reads too clean. The warning signs that show up on the production line, not in arbitration - and how to screen for them up front.
Read the article →These articles draw on the joint Gelatin Insight Report by Magnus InterGlobe and our manufacturing partner Tianran Biotech. Market figures are indicative industry ranges, not product claims; final specifications are confirmed batch-by-batch on the Certificate of Analysis.